Results 91 to 100 of about 18,546 (173)
Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project
Biologics: Targets & Therapy, 2009 Kylie Thaler1, Divya V Chandiramani2, Richard A Hansen2, Gerald Gartlehner11Department for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria; 2UNC Eshelman School of Pharmacy, University of North Carolina Kylie Thaler, Divya V Chandiramani, Richard A Hansen, et al +3 moredoaj Anakinra for dengue patients with hyperinflammation: protocol for a randomized double-blind placebo-controlled trial [version 1; peer review: 1 approved, 2 approved with reservations]
Wellcome Open ResearchBackground Novel host-directed therapies are urgently needed for patients with dengue, particularly those at high risk of developing severe disease.Angela McBride, Huynh Thi Le Duyen, Nguyen Thanh Phong, Truong Ngoc Trung, Sophie Yacoub, Ronald Geskus, Tran Bang Huyen, Evelyne Kestelyn, Dang Trong Thuan, Nguyen Thi My Linh, Tran Thi Dong Vien, Nguyen Thi Cam Huong, Phan Vinh Tho, Nguyen Minh Nguyet, Vo Thi My Hoa, Nguyen Lam Vuong, Phan Tu Qui, Dong Thi Hoai Tam, James Watson, Huynh Trung Trieu +19 moredoaj +1 more sourceImmune Dysregulation in Branched Chain Organic Acidemias
Journal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.ABSTRACT
Organic acidemias (OAs) are a group of inherited disorders, most commonly caused by defects in mitochondrial enzymes involved in amino acid and fatty acid metabolism. While they characteristically present with metabolic and neurological crises, growing evidence reveals a significant burden of chronic immune dysregulation in some disorders and ...Abdul L. Shakerdi, Jack Drda, Justin A. Dutta, Jerry Vockley +3 morewiley +1 more source2024 Update of the Asia‐Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management
International Journal of Rheumatic Diseases, Volume 29, Issue 7, July 2026.ABSTRACT Aim
To update the Asia‐Pacific League of Associations for Rheumatology (APLAR) treatment recommendations for rheumatoid arthritis (RA) by incorporating new evidence and reassessing the validity of previous guidance: Methods
A literature search for relevant publications from January 2018 to August 2023 was conducted, supplemented by earlier ...Kunihiro Yamaoka, Zhanguo Li, Khin Thin Zar Myo Aung, Paul Bird, Manisha Bhochhibhoya, Minhaj Rahim Choudhury, Debashish Danda, Tsolmon Darisuren, Rudy Hidayat, Nguyen Van Hung, Yuko Kaneko, Wanruchada Katchamart, Manjari Lahiri, Chin Teck Ng, Babur Salim, Keshav Raj Sigdel, Shereen Ch'ng Suyin, Tsutomu Takeuchi, Galymzhan Togizbayev, Evan Vista, Sandini Wijeweera, Chuanhui Xu, Chak Sing Lau +22 morewiley +1 more sourceCOVID‐19 Mortality in Swedish Intensive Care Units: A Multicenter Survival Analysis
Acta Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.ABSTRACT Background
Mortality among critically ill COVID‐19 patients has varied globally. In Sweden, geographic differences in mortality have also been observed. The current study aimed to determine whether mortality differences persist after adjusting for differences in case‐mix, and to identify potential independent factors contributing to regional ...Gustaf Forsberg, Knut Taxbro, Sören Berg, Fredrik Hammarskjöld, Johan Berkius, Håkan Johansson, Andreas Ekman, Åse Östholm, Katarina Niward, Jonna Idh, Louise Elander +10 morewiley +1 more sourceCSF1R and IL1R1 inhibitors synergistically attenuate the early pathogenesis of traumatic brain injury in mice
NeurotherapeuticsThere is an unmet need in the treatment of traumatic brain injury (TBI), a leading cause of death and disability. Colony stimulating factor 1 receptor (CSF1R) and interleukin 1 receptor type 1 (IL1R1) are critical regulators of TBI-associated ...Sudena Wang, Yong Wang, Jenny Strehle, Isa Wernersbach, Ermis Papakonstantinou, Pawit Somnuke, Katharina Ritter, Matthias Klein, Irmgard Tegeder, Michael K.E. Schäfer +9 moredoaj +1 more sourceExtracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T‐Cell Immunotherapy for B‐Cell Malignancies: A Case Series
Hematological Oncology, Volume 44, Issue 4, July 2026.Gianluca Cavallaro, Silvia Ferrari, Anna Pollastri, Elena Di Credico, Cristian Meli, Monica Rondi, Alessandro Putelli, Federico Lussana, Anna Grassi, Alessandro Rambaldi, Tino Martino Valetti, Ivano Riva, Giuseppe Gritti +12 morewiley +1 more source